Filing Details
- Accession Number:
- 0001192482-11-000264
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-06 16:15:02
- Reporting Period:
- 2011-09-01
- Filing Date:
- 2011-09-06
- Accepted Time:
- 2011-09-06 16:15:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1301081 | Pharmasset Inc | VRUS | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1397332 | Schaefer P Price | 303A College Road East Princeton NJ 08540 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value Per Share | Acquisiton | 2011-09-01 | 40,000 | $1.50 | 806,566 | No | 4 | M | Direct | |
Common Stock, $.001 Par Value Per Share | Disposition | 2011-09-01 | 40,000 | $65.63 | 766,566 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-09-01 | 40,000 | $0.00 | 40,000 | $1.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
411,915 | 2014-08-10 | No | 4 | M | Direct |
Footnotes
- This transaction is the result of standing instructions set forth in a Rule 10b5-1 plan previously established by the filer.
- The number of shares beneficially owned reflected in Items 5 and 9 of this Form 4 represent a two-for-one stock split of the Issuer's common stock which is structured in the form of a dividend payable on August 31, 2011 to the stockholders of record at the close of business on August 22, 2011.
- Represents the weighted average sales price for price increments ranging from $64.52 to $66.77.
- The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- The options were granted on August 10, 2004. 25% were vested on the one-year anniversary of the grant and 6.25% became vested quarterly thereafter.
- Following this transaction, Mr. Price has 1,286,597.34 options remaining in total from all grants, including the 411,914.66 options reported above.